Please login to the form below

Not currently logged in
Email:
Password:

Emma Walmsley

This page shows the latest Emma Walmsley news and features for those working in and with pharma, biotech and healthcare.

IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine

IFPMA industry association conference: ‘no-one left behind’ on coronavirus vaccine

The sheer scale of the pandemic means that several vaccines will be needed, said Emma Walmsley, CEO of GSK, which is contributing its vaccine adjuvant technology – which boost the immune response

Latest news

More from news
Approximately 2 fully matching, plus 48 partially matching documents found.

Latest Intelligence

  • Women Leaders in UK Healthcare: Liz Henderson Women Leaders in UK Healthcare: Liz Henderson

    It’s also great to see outside Merck that women are also progressing in other companies too – like Emma Walmsley at GSK – which gives women the inspiration that they too can

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    10. THEODORA HAROLD  . Biotech leader. While big pharma is making some significant strides in having women as their top leaders (most notably GSK’s CEO Emma Walmsley), the biotech sector, particularly

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity to Business Insider UK, ‘‘You cannot be a modern employer in an industry that should be future facing and modernising arguably

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    29. Emma Walmsley, GSK CEO. Emma Walmsley is the first-ever woman leader of a big pharma company, having taken on the CEO role at GlaxoSmithKline in April 2017. ... Since then, Walmsley has very definitely put her own stamp on the firm, making major

  • Pharma deals continue to slide Pharma deals continue to slide

    Emma Walmsley, CEO of GSK, said: “We will use cash for business development purposes, with M&A obviously dependent on the right kind of return profile.”.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics